Semaglutide News and Research

Latest Semaglutide News and Research

Researchers discover dual-functional compound that shows potential to combat type 1, type 2 diabetes

According to research published online in The FASEB Journal, scientists have discovered a dual peptide called "PGLP-1" that promotes insulin secretion and inhibits gluconeogenesis.

11 May 2017

DeNovix pink spectrophotometer - fluorometer won by Ukraine National Acaedemy of Science

DeNovix Inc.

From DeNovix Inc. 17 Apr 2017

Special edition pink spectrophotometer-fluorometer to be given away at AACR

DeNovix Inc.

From DeNovix Inc. 3 Apr 2017

Webinar on calibration and routine testing for laboratory equipment

A new webinar from METTLER TOLEDO gives participants the information they need to comply with requirements while maintaining the highest quality.

From Mettler-Toledo International Inc. 29 Mar 2017

Timing of carbohydrate intake plays role in blood glucose regulation for men with prediabetes

According to a nutrition study led by the German Institute of Human Nutrition, a partner of the German Center for Diabetes Research, the so-called internal clock also influences how people with impaired glucose metabolism react to carbohydrate-rich food.

9 Mar 2017

Best practices for pipette calibration released by Integra

In labs around the world, each day, scientists rely on pipettes to perform basic but important tasks that involve accurate and reproducible liquid sample transfers. Like any other measuring instrument – pipettes are sophisticated instruments that are typically serviced and calibrated annually to guarantee their performance.

From INTEGRA Biosciences 21 Feb 2017

DeNovix launches DS-C Cuvette Spectrophotometer for rapid, accurate UV-Vis analysis

DeNovix Inc., a developer and manufacturer of life science instrumentation for bio-research announces the launch of the DS-C Cuvette Spectrophotometer.

From DeNovix Inc. 24 Jan 2017

Epigenetic changes favor development of fatty liver in humans and mice

Mice with a strong tendency to obesity already exhibit epigenetic changes at six weeks of age, inducing the liver to amplify its production of the enzyme DPP4 and release it into the circulation. Over the long term, this favors the development of a fatty liver.

9 Jan 2017

Platypus venom shows potential for new diabetes treatments

Australian researchers have discovered remarkable evolutionary changes to insulin regulation in two of the nation's most iconic native animal species - the platypus and the echidna - which could pave the way for new treatments for type 2 diabetes in humans.

29 Nov 2016

Medovex successfully conducts live tissue test of DenerveX System

Medovex Corp., a developer of medical technology products, today announced that the company conducted a successful live tissue test of the DenerveX System under the most stringent standards required by FDA and other regulatory agencies.

4 Nov 2016

METTLER TOLEDO releases new weighing guide to optimize lab performance

In the highly competitive pharmaceutical industry, there is intense focus on laboratory efficiency. However, there are also stringent regulations to adhere to.

From Mettler-Toledo International Inc. 2 Nov 2016

Esperite's business unit develops therapy for Crohn's disease perianal fistulas

Esperite's business unit The Cell Factory in collaboration with Women's and Children's Health Department of the University of Padua and the Padua University Hospital are developing therapies for inflammatory bowel disease (IBD) using extracellular vesicles (EVs).

21 Oct 2016

OGT announces expansion of Cytocell Aquarius Haematology FISH probe range

Oxford Gene Technology, The Molecular Genetics Company, has today announced a significant expansion of its existing catalogue of Cytocell Aquarius Haematology probes for fluorescence in situ hybridisation (FISH) — underlining the company's position as the one-stop-shop for high-quality FISH probes.

13 Oct 2016

Clinical trial to examine effectiveness of diabetes drug to slow or stop progression of Parkinson's

Type II diabetes and Parkinson's disease may not appear to have much in common but a look below the surface reveals important molecular similarities that provide a potential target for fighting Parkinson's.

8 Sep 2016

Study shows diabetes drug ineffective in improving condition of patients with advanced heart failure

In an attempt to correct defects in the energy generation that contribute to poor pump function among heart failure patients, researchers examined whether the diabetes drug liraglutide, could improve the condition of patients with advanced heart failure.

2 Aug 2016

Semaglutide News and Research

Latest Semaglutide News and Research

Researchers discover dual-functional compound that shows potential to combat type 1, type 2 diabetes

DeNovix pink spectrophotometer - fluorometer won by Ukraine National Acaedemy of Science

Special edition pink spectrophotometer-fluorometer to be given away at AACR

Webinar on calibration and routine testing for laboratory equipment

Timing of carbohydrate intake plays role in blood glucose regulation for men with prediabetes

Best practices for pipette calibration released by Integra

DeNovix launches DS-C Cuvette Spectrophotometer for rapid, accurate UV-Vis analysis

Epigenetic changes favor development of fatty liver in humans and mice

Platypus venom shows potential for new diabetes treatments

Medovex successfully conducts live tissue test of DenerveX System

METTLER TOLEDO releases new weighing guide to optimize lab performance

Esperite's business unit develops therapy for Crohn's disease perianal fistulas

OGT announces expansion of Cytocell Aquarius Haematology FISH probe range

Clinical trial to examine effectiveness of diabetes drug to slow or stop progression of Parkinson's

Study shows diabetes drug ineffective in improving condition of patients with advanced heart failure

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

Appetite hormone CART helps increase insulin secretion, reduce glucagon production

Liraglutide cardioprotective in high-risk Type 2 diabetes patients

Liraglutide drug effectively decreases cardiovascular disease risk in type 2 diabetes patients

New technique could help reduce chances of drug failure during later stages of clinical trials

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Semaglutide News and Research

Latest Semaglutide News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in